Treatment of Primary Focal Hyperhidrosis
For primary focal hyperhidrosis, begin with topical aluminum chloride 10-20% as first-line therapy, escalate to botulinum toxin injections for axillary involvement or oral glycopyrrolate 1-2 mg once or twice daily for craniofacial involvement if topical therapy fails, and reserve surgical options for refractory cases. 1, 2
Initial Diagnostic Evaluation
Before initiating treatment, distinguish primary from secondary hyperhidrosis, as this fundamentally changes management:
- Primary hyperhidrosis affects axillae, palms, soles, or craniofacial regions bilaterally and does NOT occur at night 1
- Nocturnal sweating almost always indicates secondary causes requiring evaluation for sleep disorders, cardiovascular disease, endocrine disorders, or neurological conditions 1
- Perform a comprehensive medication review, as many drugs cause secondary hyperhidrosis 1, 2
- Check vital signs including orthostatic blood pressure 1
- Examine sweating distribution, thyroid abnormalities, peripheral edema, and scalp for scaling or inflammation if craniofacial involvement present 1
Laboratory Testing for Suspected Secondary Hyperhidrosis
Order complete blood count, comprehensive metabolic panel, thyroid function tests, hemoglobin A1c, iron studies, vitamin D, zinc levels, and serum calcium 1, 2, 3. Additional testing based on clinical suspicion may include overnight oximetry or polysomnography for sleep disorders, ECG and BNP for cardiovascular concerns, and morning urine osmolality and PTH for endocrine evaluation 1.
Treatment Algorithm by Anatomic Location
Axillary Hyperhidrosis
First-line: Topical aluminum chloride 10-20% solution 3, 4, 5, 6
Second-line: OnabotulinumtoxinA (Botox) injections, which is FDA-approved for severe primary axillary hyperhidrosis 1, 7, 8. This provides 3-6 months of relief but requires repeated treatments 3. The FDA label confirms this indication for "severe primary axillary hyperhidrosis when medicines used on the skin (topical) do not work well enough" 7.
Third-line: Oral glycopyrrolate 1-2 mg once or twice daily 1
Refractory cases: Consider iontophoresis, microwave therapy, or surgical options including suction curettage or sympathectomy 4, 9
Craniofacial Hyperhidrosis
First-line: Oral glycopyrrolate 1-2 mg once or twice daily OR topical glycopyrrolate 1, 2
- Note that topical aluminum chloride 10-20% may cause irritation or scaling on the scalp 1, 2
- If using topical aluminum chloride and scaling develops, check vitamin D levels and consider high-potency topical steroids if inflammation develops 1, 2
Second-line: Botulinum toxin A injections, requiring careful technique to avoid facial weakness 1, 2
Palmar and Plantar Hyperhidrosis
First-line: Iontophoresis 4, 5, 9
Second-line: Botulinum toxin injections 8, 4, 5
Third-line: Oral glycopyrrolate 5, 9
Refractory cases: Sympathectomy for palmar hyperhidrosis after failure of less invasive options 4, 9
Critical Safety Considerations with Botulinum Toxin
The FDA label for botulinum toxin carries serious warnings that must be understood 7:
- Spread of toxin effects can cause symptoms of botulism including loss of strength, muscle weakness, double vision, hoarseness, trouble speaking, loss of bladder control, trouble breathing, and trouble swallowing 7
- These symptoms can occur hours to weeks after injection 7
- Death can occur as a complication with severe swallowing or breathing problems 7
- However, "there has not been a confirmed serious case of spread of toxin effect away from the injection site when BOTOX has been used at the recommended dose to treat severe underarm sweating" 7
- May cause temporary weakness in adjacent muscles depending on injection site 2, 3
Oral Anticholinergic Therapy: Glycopyrrolate
When using oral glycopyrrolate 1-2 mg once or twice daily 1, 2:
- Anticholinergic side effects include dry mouth, blurred vision, urinary retention, and constipation 1, 2
- Elderly patients require close monitoring for cognitive effects and fall risk 1
- Despite effectiveness, chronic use may result in detrimental adverse effects 9
Common Pitfalls to Avoid
- Failing to distinguish primary from secondary hyperhidrosis leads to inappropriate treatment 1
- Overlooking medications as causes of secondary hyperhidrosis 1
- Ignoring nocturnal sweating as a red flag for serious underlying conditions like malignancy 1
- Using simple excision for chronic lesions without considering deroofing techniques 3
- Escalating methylprednisolone above 2 mg/kg/day provides no additional benefit 3
Supportive Measures
Recommend avoiding known triggers such as spicy foods, caffeine, and alcohol, and advise wearing moisture-wicking materials and appropriate headwear 2. Maintain regular scalp hygiene to prevent secondary complications 2. Monitor for side effects of medications and schedule regular follow-up every 3-6 months to adjust treatment as needed 2.